GUEST POST: NorthStar VETS Uses TANOVEA-CA1 for Canine Lymphoma Patients

Posted on May 10th, 2018 by VetDC

NorthStar VETS, New Jersey – NorthStar VETS recently began using TANOVEA-CA1 in the treatment of 8-year-old Stella. Stella was diagnosed with lymphoma in March 2017. She nearly completed two cycles of CHOP chemotherapy when her disease progressed. In April 2018 … Keep Reading

Have You Considered Pet Insurance? A Brief Overview.

Posted on February 27th, 2018 by VetDC

As veterinary medicine advances with breakthroughs like TANOVEA™-CA1 (rabacfosadine for injection) cancer treatment for dogs, our pets have the opportunity to live longer, healthier lives. However, even as pet owners celebrate that fact, they have to consider the cost of … Keep Reading

Guest Blog: Helping Your Beloved Canine Fight Cancer

Posted on February 15th, 2018 by VetDC

BY JENN JOHNSON, BOSTON, MASS. — Treating cancer is no walk in the park for everyone involved, whether they’re the patient, physician or caregiver. When dogs are afflicted with this dangerous disease, as their master and primary caregiver, we want … Keep Reading

Guest Blog: Understanding Canine Cancer & Coping With This Deadly Disease

Posted on January 24th, 2018 by VetDC

BY JENN JOHNSON, BOSTON, MASS. — There’s no easy way to say it, coping with cancer is devastating at best. Whether it’s a beloved friend, family member or a pet (which is all of these characters combined into one in … Keep Reading

New Year, New Focus on Food Safety for Your Dog

Posted on January 9th, 2018 by VetDC

As the New Year gets underway, many people will make resolutions about eating better. But, it’s also an excellent time to focus on food safety for your dog. While eating the wrong “people foods” won’t cause cancer in dogs, it … Keep Reading

(Video) VCS Interview with Dr. Andrew Novosad

Posted on December 15th, 2017 by VetDC

Dr. Sue Cancer Vet posted an oncologist interview with Dr. Andrew Novosad as part of her VCS interview series. Novosad described TANOVEA-CA1 (rabacfosadine for injection) as the most significant highlight of this year’s VCS Conference and shared why he is so … Keep Reading

November TANOVEA®-CA1 Webinar Vlog – Anticipating and Addressing Adverse Effects

Posted on November 22nd, 2017 by VetDC

As part of a TANOVEA CA-1 Tuesdays webinar, Douglas H. Thamm, VMD, DACVIM (Oncology), presents information for veterinarians on possible adverse effects of treatment with the canine lymphoma drug, and explores strategies for anticipating and mitigating common gastrointestinal effects. This … Keep Reading

Cancer Treatment for Dogs and How Dogs Improve Our Health

Posted on November 9th, 2017 by VetDC

When your canine companion receives a lymphoma diagnosis, you naturally seek the latest cancer treatment for dogs (such as TANOVEA®-CA1 (rabacfosadine for injection)). But its not just owners who take care of dogs, dogs also take care of us. Studies have shown … Keep Reading

VetDC Announces New TANOVEA®-CA1 Publication, State of the Art Presentation at VCS 2017 Annual Conference

Posted on November 3rd, 2017 by VetDC

FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology. Data from this publication and several new VetDC-sponsored studies was prominently featured in a State … Keep Reading

TANOVEA-CA1 Noted in Veterinary Brief Article

Posted on October 25th, 2017 by VetDC

As Sue Ettinger, DVM, DACVIM (Oncology), of Tarrytown, New York, explains in a new article on the Veterinary Brief website, canine lymphoma, one of the most common canine cancers, is actually a collection of cancers arising from the malignant transformation … Keep Reading